RankAlpha logo
Back to Rankings

PHVS

PharvarisC
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
View Chart
+
Peers tracked
8
U.S. public peers
Grade Position
In line
vs peer average
PHVS vs peer average
55/100
PHVS vs. peer average (C vs. C)
Grade spread
A 1 · B 1 · C 2 · D 1 · F 2
Graded peers loaded
Coverage
8 graded
100% of tracked

Peer overview

TRVI is the first available peer comparator.

Same sector: Pharmaceuticals, Biotechnology & Life Sciences · Cap $2.05B

✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
Top peerTRVITrevi Therapeutics
PHVS
Pharvaris
TRVI
Trevi Therapeutics
Grade
C
D
Momentum
67
82
Value
41
41
Sentiment
-
0
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Mixed
Defensive
Open Side-by-Side ComparisonCompare all

Grade position vs TRVI

PHVS / TRVI
Grade Position
In line
PHVS vs. peer average (C vs. C)
55/100
Momentum
67
TRVI
Value
41
PHVS
Sentiment
-
-

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs PHVS
1
TRVI
Trevi Therapeutics Inc Common
F
20/100
+2
2
GENB
Generate Biomedicines Inc Common
N/A
-
-
3
BHC
Bausch Health Companies Inc Common
B
80/100
-1
4
NBTX
Nanobiotix SA ADR
F
20/100
+2
5
OCUL
Ocular Therapeutix Inc Common
C
60/100
Even
TRVI is the first peer returned for this comparison set.